BioSpace News Archive

Hillstream BioPharma, Inc. today announced that an abstract highlighting the progress of HSB-1216 pipeline candidate is being presented as an online publication only at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from June 4-8, 2021.

HAVN Life Sciences Inc., a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce the completion of the previously announced acquisition of clinical stage intellectual property from Bolt Therapeutics.

Fastest Labs, a Drug, Alcohol and DNA Testing franchise, has added a new location in Cookeville, Tennessee to its growing list of facilities across America.

On May 31, 2021 , Porton Biologics Ltd. (hereinafter referred to as Portonbio) announced a strategic cooperation with Nanjing KAEDI Biotech, Inc. (hereinafter referred to as KAEDI). Portonbio will offer CMC services for KAEDI’s CAR-T cell therapies with its end-to-end CDMO platform for gene and cell therapies to help accelerate their development process.

Resolve Biosciences today announced the commercial launch of its groundbreaking Molecular Cartography™ service offering to provide scientists with the highest-resolution view of subcellular gene expression.

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the appointment of industry veteran Zelanna Goldberg, M.D., M.A.S. as its Chief Medical Officer. Dr. Goldberg joins Alpine from Iovance Biotherapeutics, where she was Senior Vice President, Clinical Science.

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it has rescheduled its conference call and webcast to Monday, June 14, 2021 @ 8:00 am ET

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the United States Patent and Trademark Office (USPTO) issued US patent No. 11,020,361 to the Company related to Gimoti® (metoclopramide) nasal spray.

AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 42 nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 .

- Study demonstrated 100% survival in dogs treated with KIND-030, even in the absence of any supportive care, versus 43% survival in dogs treated with placebo